Literature DB >> 21318738

Comparative genetics of the central nervous system in epigean and hypogean Astyanax mexicanus.

Allen G Strickler1, Daphne Soares.   

Abstract

The extreme environment of subterranean caves presents an adaptive challenge to troglobitic organisms. The mechanisms by which natural selection modify an ancestral surface neural circuit to produce a novel subterranean behavior remain a mystery. To address this question, we performed cross species microarray experiments to compare differences in gene expression levels in the adult brain of the teleost Astyanax mexicanus. This species provides a unique opportunity for comparative genetic studies as it consists of extant epigean (surface) and hypogean (cave) conspecifics. Microarray experiments herein revealed significant changes in transcription levels of seventeen genes, several of which are important for behaviors involved in metabolic management. We focused on genes central to three neurotransmission and neuromodulation networks: the endocannabinoid system (Cannabinoid receptor CB1), the dopaminergic system (Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein) and the glutamatergic system (glutamate receptor AMPA 2a). All three genes were upregulated in the hypogean form of A. mexicanus compared to the epigean form, indicating that behavioral differences in the hypogean form of the species could be due to alterations in expression levels of several key genes. This information provides insights into the complex relationships among environmental factors, genetics, nervous systems and adaptive behavior, and can subsequently help us understand how these interactions affect behavior in other biological systems.

Entities:  

Mesh:

Year:  2011        PMID: 21318738     DOI: 10.1007/s10709-011-9557-1

Source DB:  PubMed          Journal:  Genetica        ISSN: 0016-6707            Impact factor:   1.082


  53 in total

1.  Stimulus-coupled interaction of tyrosine hydroxylase with 14-3-3 proteins.

Authors:  C Itagaki; T Isobe; M Taoka; T Natsume; N Nomura; T Horigome; S Omata; H Ichinose; T Nagatsu; L A Greene; T Ichimura
Journal:  Biochemistry       Date:  1999-11-23       Impact factor: 3.162

2.  Differential responsiveness of dopamine transmission to food-stimuli in nucleus accumbens shell/core compartments.

Authors:  V Bassareo; G Di Chiara
Journal:  Neuroscience       Date:  1999-03       Impact factor: 3.590

Review 3.  The glutamate receptor ion channels.

Authors:  R Dingledine; K Borges; D Bowie; S F Traynelis
Journal:  Pharmacol Rev       Date:  1999-03       Impact factor: 25.468

Review 4.  The endocannabinoid system and the treatment of obesity.

Authors:  Uberto Pagotto; Valentina Vicennati; Renato Pasquali
Journal:  Ann Med       Date:  2005       Impact factor: 4.709

5.  Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity.

Authors:  Douglas Osei-Hyiaman; Michael DePetrillo; Pál Pacher; Jie Liu; Svetlana Radaeva; Sándor Bátkai; Judith Harvey-White; Ken Mackie; László Offertáler; Lei Wang; George Kunos
Journal:  J Clin Invest       Date:  2005-05       Impact factor: 14.808

6.  Down-regulation of cannabinoid-1 (CB-1) receptors in specific extrahypothalamic regions of rats with dietary obesity: a role for endogenous cannabinoids in driving appetite for palatable food?

Authors:  Joanne A Harrold; Joanne C Elliott; Peter J King; Peter S Widdowson; Gareth Williams
Journal:  Brain Res       Date:  2002-10-18       Impact factor: 3.252

7.  Endocannabinoids mediate the effects of acute stress and corticosterone on sex behavior.

Authors:  Emma Coddington; Christine Lewis; James D Rose; Frank L Moore
Journal:  Endocrinology       Date:  2006-11-09       Impact factor: 4.736

8.  Differentially expressed genes identified by cross-species microarray in the blind cavefish Astyanax.

Authors:  Allen G Strickler; William R Jeffery
Journal:  Integr Zool       Date:  2009-03       Impact factor: 2.654

9.  The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis.

Authors:  Daniela Cota; Giovanni Marsicano; Matthias Tschöp; Yvonne Grübler; Cornelia Flachskamm; Mirjam Schubert; Dorothee Auer; Alexander Yassouridis; Christa Thöne-Reineke; Sylvia Ortmann; Federica Tomassoni; Cristina Cervino; Enzo Nisoli; Astrid C E Linthorst; Renato Pasquali; Beat Lutz; Günter K Stalla; Uberto Pagotto
Journal:  J Clin Invest       Date:  2003-08       Impact factor: 14.808

Review 10.  Functional genomic approaches using the nematode Caenorhabditis elegans as a model system.

Authors:  Junho Lee; Seunghee Nam; Soon Baek Hwang; Mingi Hong; Jae Young Kwon; Kyu Sang Joeng; Seol Hee Im; Jiwon Shim; Moon Cheol Park
Journal:  J Biochem Mol Biol       Date:  2004-01-31
View more
  5 in total

1.  Differences in behavior between surface and cave Astyanax mexicanus may be mediated by changes in catecholamine signaling.

Authors:  Kathryn Gallman; Eric Fortune; Daihana Rivera; Daphne Soares
Journal:  J Comp Neurol       Date:  2020-05-18       Impact factor: 3.215

2.  Loss of schooling behavior in cavefish through sight-dependent and sight-independent mechanisms.

Authors:  Johanna E Kowalko; Nicolas Rohner; Santiago B Rompani; Brant K Peterson; Tess A Linden; Masato Yoshizawa; Emily H Kay; Jesse Weber; Hopi E Hoekstra; William R Jeffery; Richard Borowsky; Clifford J Tabin
Journal:  Curr Biol       Date:  2013-09-12       Impact factor: 10.834

3.  Feed or fight: A behavioral shift in blind cavefish.

Authors:  Sylvie Rétaux; Yannick Elipot
Journal:  Commun Integr Biol       Date:  2013-03-01

4.  The energetic cost of vision and the evolution of eyeless Mexican cavefish.

Authors:  Damian Moran; Rowan Softley; Eric J Warrant
Journal:  Sci Adv       Date:  2015-09-11       Impact factor: 14.136

5.  A potential benefit of albinism in Astyanax cavefish: downregulation of the oca2 gene increases tyrosine and catecholamine levels as an alternative to melanin synthesis.

Authors:  Helena Bilandžija; Li Ma; Amy Parkhurst; William R Jeffery
Journal:  PLoS One       Date:  2013-11-25       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.